Selected research
Industry Research
Custom Antibody Development and Production Service Industry Research Report 2026
Market perspective
The global Custom Antibody Development and Production Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Custom Antibody Development and Production Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Custom Antibody Development and Production Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Custom Antibody Development and Production Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Custom Antibody Development and Production Service include Thermo Fisher Scientific, Sino Biological, Inotiv, GenScript, R&D Systems, Proteogenix, BBI Solutions, Bio-Rad Laboratories and Bio-Techne, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Custom Antibody Development and Production Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Custom Antibody Development and Production Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Custom Antibody Development and Production Service Market by Company
Thermo Fisher Scientific
Sino Biological
Inotiv
GenScript
R&D Systems
Proteogenix
BBI Solutions
Bio-Rad Laboratories
Bio-Techne
Abcam
OriGene
Innovagen
AltaBioscience
Creative Biolabs
Rockland
Biosynth
ProSci
Abclonal
Eurogentec
Creative Diagnostics
BioGenes
Biomolecular Discovery Services, LLC.
Proteintech Group
HUABIO
MyBioSource
Custom Antibody Development and Production Service Segment by Type
Polyclonal Antibody
Monoclonal Antibody
Recombinant Antibody
Custom Antibody Development and Production Service Segment by Application
Research
Diagnosis
Treatment and Clinical Practice
Custom Antibody Development and Production Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Antibody Development and Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Antibody Development and Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Antibody Development and Production Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Custom Antibody Development and Production Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyclonal Antibody
- Monoclonal Antibody
- Recombinant Antibody
Applications
- Research
- Diagnosis
- Treatment and Clinical Practice
Companies covered
- Thermo Fisher Scientific
- Sino Biological
- Inotiv
- GenScript
- R&D Systems
- Proteogenix
- BBI Solutions
- Bio-Rad Laboratories
- Bio-Techne
- Abcam
- OriGene
- Innovagen
- AltaBioscience
- Creative Biolabs
- Rockland
- Biosynth
- ProSci
- Abclonal
- Eurogentec
- Creative Diagnostics
- BioGenes
- Biomolecular Discovery Services, LLC.
- Proteintech Group
- HUABIO
- MyBioSource
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Custom Antibody Development and Production Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Polyclonal Antibody
- 2.2.3 Monoclonal Antibody
- 2.2.4 Recombinant Antibody
- 2.3 Custom Antibody Development and Production Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Research
- 2.3.3 Diagnosis
- 2.3.4 Treatment and Clinical Practice
- 2.4 Assumptions and Limitations
3 Custom Antibody Development and Production Service Breakdown Data by Type
- 3.1 Global Custom Antibody Development and Production Service Historic Market Size by Type (2021-2026)
- 3.2 Global Custom Antibody Development and Production Service Forecasted Market Size by Type (2027-2032)
4 Custom Antibody Development and Production Service Breakdown Data by Application
- 4.1 Global Custom Antibody Development and Production Service Historic Market Size by Application (2021-2026)
- 4.2 Global Custom Antibody Development and Production Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Custom Antibody Development and Production Service Market Perspective (2021-2032)
- 5.2 Global Custom Antibody Development and Production Service Growth Trends by Region
- 5.2.1 Global Custom Antibody Development and Production Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Custom Antibody Development and Production Service Historic Market Size by Region (2021-2026)
- 5.2.3 Custom Antibody Development and Production Service Forecasted Market Size by Region (2027-2032)
- 5.3 Custom Antibody Development and Production Service Market Dynamics
- 5.3.1 Custom Antibody Development and Production Service Industry Trends
- 5.3.2 Custom Antibody Development and Production Service Market Drivers
- 5.3.3 Custom Antibody Development and Production Service Market Challenges
- 5.3.4 Custom Antibody Development and Production Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Custom Antibody Development and Production Service Players by Revenue
- 6.1.1 Global Top Custom Antibody Development and Production Service Players by Revenue (2021-2026)
- 6.1.2 Global Custom Antibody Development and Production Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Custom Antibody Development and Production Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Custom Antibody Development and Production Service Head Office and Area Served
- 6.4 Global Custom Antibody Development and Production Service Players, Product Type & Application
- 6.5 Global Custom Antibody Development and Production Service Manufacturers Established Date
- 6.6 Global Custom Antibody Development and Production Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Custom Antibody Development and Production Service Market Size (2021-2032)
- 7.2 North America Custom Antibody Development and Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Custom Antibody Development and Production Service Market Size by Country (2021-2026)
- 7.4 North America Custom Antibody Development and Production Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Custom Antibody Development and Production Service Market Size (2021-2032)
- 8.2 Europe Custom Antibody Development and Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Custom Antibody Development and Production Service Market Size by Country (2021-2026)
- 8.4 Europe Custom Antibody Development and Production Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Custom Antibody Development and Production Service Market Size (2021-2032)
- 9.2 Asia-Pacific Custom Antibody Development and Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Custom Antibody Development and Production Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Custom Antibody Development and Production Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Custom Antibody Development and Production Service Market Size (2021-2032)
- 10.2 South America Custom Antibody Development and Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Custom Antibody Development and Production Service Market Size by Country (2021-2026)
- 10.4 South America Custom Antibody Development and Production Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Custom Antibody Development and Production Service Market Size (2021-2032)
- 11.2 Middle East & Africa Custom Antibody Development and Production Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Custom Antibody Development and Production Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Custom Antibody Development and Production Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Custom Antibody Development and Production Service Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Sino Biological
- 12.2.1 Sino Biological Company Information
- 12.2.2 Sino Biological Business Overview
- 12.2.3 Sino Biological Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.2.4 Sino Biological Custom Antibody Development and Production Service Product Portfolio
- 12.2.5 Sino Biological Recent Developments
- 12.3 Inotiv
- 12.3.1 Inotiv Company Information
- 12.3.2 Inotiv Business Overview
- 12.3.3 Inotiv Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.3.4 Inotiv Custom Antibody Development and Production Service Product Portfolio
- 12.3.5 Inotiv Recent Developments
- 12.4 GenScript
- 12.4.1 GenScript Company Information
- 12.4.2 GenScript Business Overview
- 12.4.3 GenScript Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.4.4 GenScript Custom Antibody Development and Production Service Product Portfolio
- 12.4.5 GenScript Recent Developments
- 12.5 R&D Systems
- 12.5.1 R&D Systems Company Information
- 12.5.2 R&D Systems Business Overview
- 12.5.3 R&D Systems Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.5.4 R&D Systems Custom Antibody Development and Production Service Product Portfolio
- 12.5.5 R&D Systems Recent Developments
- 12.6 Proteogenix
- 12.6.1 Proteogenix Company Information
- 12.6.2 Proteogenix Business Overview
- 12.6.3 Proteogenix Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.6.4 Proteogenix Custom Antibody Development and Production Service Product Portfolio
- 12.6.5 Proteogenix Recent Developments
- 12.7 BBI Solutions
- 12.7.1 BBI Solutions Company Information
- 12.7.2 BBI Solutions Business Overview
- 12.7.3 BBI Solutions Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.7.4 BBI Solutions Custom Antibody Development and Production Service Product Portfolio
- 12.7.5 BBI Solutions Recent Developments
- 12.8 Bio-Rad Laboratories
- 12.8.1 Bio-Rad Laboratories Company Information
- 12.8.2 Bio-Rad Laboratories Business Overview
- 12.8.3 Bio-Rad Laboratories Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.8.4 Bio-Rad Laboratories Custom Antibody Development and Production Service Product Portfolio
- 12.8.5 Bio-Rad Laboratories Recent Developments
- 12.9 Bio-Techne
- 12.9.1 Bio-Techne Company Information
- 12.9.2 Bio-Techne Business Overview
- 12.9.3 Bio-Techne Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.9.4 Bio-Techne Custom Antibody Development and Production Service Product Portfolio
- 12.9.5 Bio-Techne Recent Developments
- 12.10 Abcam
- 12.10.1 Abcam Company Information
- 12.10.2 Abcam Business Overview
- 12.10.3 Abcam Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.10.4 Abcam Custom Antibody Development and Production Service Product Portfolio
- 12.10.5 Abcam Recent Developments
- 12.11 OriGene
- 12.11.1 OriGene Company Information
- 12.11.2 OriGene Business Overview
- 12.11.3 OriGene Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.11.4 OriGene Custom Antibody Development and Production Service Product Portfolio
- 12.11.5 OriGene Recent Developments
- 12.12 Innovagen
- 12.12.1 Innovagen Company Information
- 12.12.2 Innovagen Business Overview
- 12.12.3 Innovagen Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.12.4 Innovagen Custom Antibody Development and Production Service Product Portfolio
- 12.12.5 Innovagen Recent Developments
- 12.13 AltaBioscience
- 12.13.1 AltaBioscience Company Information
- 12.13.2 AltaBioscience Business Overview
- 12.13.3 AltaBioscience Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.13.4 AltaBioscience Custom Antibody Development and Production Service Product Portfolio
- 12.13.5 AltaBioscience Recent Developments
- 12.14 Creative Biolabs
- 12.14.1 Creative Biolabs Company Information
- 12.14.2 Creative Biolabs Business Overview
- 12.14.3 Creative Biolabs Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.14.4 Creative Biolabs Custom Antibody Development and Production Service Product Portfolio
- 12.14.5 Creative Biolabs Recent Developments
- 12.15 Rockland
- 12.15.1 Rockland Company Information
- 12.15.2 Rockland Business Overview
- 12.15.3 Rockland Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.15.4 Rockland Custom Antibody Development and Production Service Product Portfolio
- 12.15.5 Rockland Recent Developments
- 12.16 Biosynth
- 12.16.1 Biosynth Company Information
- 12.16.2 Biosynth Business Overview
- 12.16.3 Biosynth Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.16.4 Biosynth Custom Antibody Development and Production Service Product Portfolio
- 12.16.5 Biosynth Recent Developments
- 12.17 ProSci
- 12.17.1 ProSci Company Information
- 12.17.2 ProSci Business Overview
- 12.17.3 ProSci Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.17.4 ProSci Custom Antibody Development and Production Service Product Portfolio
- 12.17.5 ProSci Recent Developments
- 12.18 Abclonal
- 12.18.1 Abclonal Company Information
- 12.18.2 Abclonal Business Overview
- 12.18.3 Abclonal Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.18.4 Abclonal Custom Antibody Development and Production Service Product Portfolio
- 12.18.5 Abclonal Recent Developments
- 12.19 Eurogentec
- 12.19.1 Eurogentec Company Information
- 12.19.2 Eurogentec Business Overview
- 12.19.3 Eurogentec Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.19.4 Eurogentec Custom Antibody Development and Production Service Product Portfolio
- 12.19.5 Eurogentec Recent Developments
- 12.20 Creative Diagnostics
- 12.20.1 Creative Diagnostics Company Information
- 12.20.2 Creative Diagnostics Business Overview
- 12.20.3 Creative Diagnostics Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.20.4 Creative Diagnostics Custom Antibody Development and Production Service Product Portfolio
- 12.20.5 Creative Diagnostics Recent Developments
- 12.21 BioGenes
- 12.21.1 BioGenes Company Information
- 12.21.2 BioGenes Business Overview
- 12.21.3 BioGenes Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.21.4 BioGenes Custom Antibody Development and Production Service Product Portfolio
- 12.21.5 BioGenes Recent Developments
- 12.22 Biomolecular Discovery Services, LLC.
- 12.22.1 Biomolecular Discovery Services, LLC. Company Information
- 12.22.2 Biomolecular Discovery Services, LLC. Business Overview
- 12.22.3 Biomolecular Discovery Services, LLC. Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.22.4 Biomolecular Discovery Services, LLC. Custom Antibody Development and Production Service Product Portfolio
- 12.22.5 Biomolecular Discovery Services, LLC. Recent Developments
- 12.23 Proteintech Group
- 12.23.1 Proteintech Group Company Information
- 12.23.2 Proteintech Group Business Overview
- 12.23.3 Proteintech Group Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.23.4 Proteintech Group Custom Antibody Development and Production Service Product Portfolio
- 12.23.5 Proteintech Group Recent Developments
- 12.24 HUABIO
- 12.24.1 HUABIO Company Information
- 12.24.2 HUABIO Business Overview
- 12.24.3 HUABIO Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.24.4 HUABIO Custom Antibody Development and Production Service Product Portfolio
- 12.24.5 HUABIO Recent Developments
- 12.25 MyBioSource
- 12.25.1 MyBioSource Company Information
- 12.25.2 MyBioSource Business Overview
- 12.25.3 MyBioSource Revenue in Custom Antibody Development and Production Service Business (2021-2026)
- 12.25.4 MyBioSource Custom Antibody Development and Production Service Product Portfolio
- 12.25.5 MyBioSource Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst